Alfasigma's $800 million buyout of Intercept Pharma two years ago is starting to look like a poor bet, as its only approved product, Ocaliva, is pulled off the market in the US and all trials of the ...

Homeland Security Secretary Kristi Noem told a preposterous story demonizing immigrants in high-profile public remarks alongside President Donald Trump and on Fox News last summer, about a cannibal ...

The North American Aerospace Defense Command (NORAD) launched multiple U.S. fighter jets after tracking Russian military aircraft operating in the Alaskan Air Defense Identification Zone (ADIZ) on ...

The Trump administration is increasing the U.S. military’s presence in Nigeria, where decades of American military assistance has coincided with increased violence and instability. About 100 U.S.

The end-game of The First Descendant thrives largely on its Void Intercept Battles. Throughout the main campaign of this game, there are story bosses from the Vulgas like Eterllick, but the Void ...

Moderator, "Face the Nation with Margaret Brennan;" Chief foreign affairs correspondent Margaret Brennan is moderator of "Face the Nation with Margaret Brennan" on CBS. Based in Washington, D.C., ...

After a long run of regulatory stumbles and the recent withdrawal of its lone commercial drug from the U.S. market, Intercept Pharmaceuticals is implementing a restructuring and rounds of job cuts in ...

Once again, Israeli bombs rained down on Gaza. The latest wave of strikes killed more than 100 people, mostly women and children, according to health authorities. The bombardment marked the deadliest ...

U.S. fighter jets scrambled Wednesday to intercept four Russian warplanes off the coast of Alaska, the North American Aerospace Defense Command (NORAD) said Thursday. NORAD said in a statement it ...

While the path for any drug to go from lab research to commercialization takes years, Intercept Pharmaceuticals now stands as another example that a product’s market exit can also be long and winding.

Please provide your email address to receive an email when new articles are posted on . Intercept has voluntarily withdrawn its lone product, Ocaliva, from U.S. market for primary biliary cholangitis.